Header Logo

Connection

BEHRANG AMINI to Response Evaluation Criteria in Solid Tumors

Back to Details
This is a "connection" page, showing publications BEHRANG AMINI has written about Response Evaluation Criteria in Solid Tumors.
BEHRANG AMINI
Connection Strength
0.035
Response Evaluation Criteria in Solid Tumors
  1. Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion. Oncology. 2016; 91(6):348-353.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.